A self-purifying microfluidic system for identifying drugs acting against adult schistosomes

Abstract

The discovery of novel antihelmintic molecules to combat the development and spread of schistosomiasis, a disease caused by several Schistosoma flatworm species, mobilizes significant research efforts worldwide. With a limited number of biochemical assays for measuring the viability of adult worms, the antischistosomicidal activity of molecules is usually evaluated by a microscopic observation of worm mobility and/or integrity upon drug exposure. Even if these phenotypical assays enable multiple parameters analysis, they are often conducted during several days and need to be associated with image-based analysis to minimized subjectivity. We describe here a self-purifying microfluidic system enabling the selection of healthy adult worms and the identification of molecules acting instantly on the parasite. The worms are assayed in a dynamic environment that eliminates unhealthy worms that cannot attach firmly to the chip walls prior to being exposed to the drug. The detachment of the worms is also used as second step readout for identifying active compounds. We have validated this new fluidic screening approach using the two major antihelmintic drugs, praziquantel and artemisinin. The reported dynamic system is simple to produce and to parallelize. Importantly, it enables a quick and sensitive detection of antischistosomal compounds in no more than one hour.

Optimized protocols for RNA interference in Macrostomum lignano

“…Assuming the typical normality of biological replicates generated by qPCR analysis and fluorescence measurements (n from 2–4) ( Goni et al . 2009 ; Girod et al . 2022 ), statistical significance of differences and corresponding levels of confidence ( P -values) were calculated by 1-way ANOVA analysis, followed up by Holm-Sidak method tests with an α risk of 5% ( P < 0.05) between controls and experimental conditions, or between paired conditions.…”